Abstract Library

#3359 Delayed gastric emptying in autoimmune metaplastic atrophic gastritis

Introduction: Symptoms of patients diagnosed with autoimmune metaplastic atrophic gastritis (AMAG) are not specific. Some patients may present symptoms of delayed gastric emptying.

Conference:

Presenting Author: Hu H

Authors: Hu H, Li R, Wang W, Zhang S,

Keywords: Autoimmune metaplastic atrophic gastritis, delayed gastric emptying, gastric emptying T ½ time, functional dyspepsia,

#3098 The incidence rate and clinical characteristics of autoimmune metaplastic atrophic gastritis and associated neoplasia in Chinese patients

Introduction: The incidence rate of autoimmune metaplastic atrophic gastritis (AMAG) is on the rise gradually and it may lead to an increased risk of associated gastric neoplastic lesions. However, there is limited literature about the respective incidence of neoplasia with AMAG, such as gastric neuroendocrine tumors (g-NETs), gastric hyperplastic polyps (GHPs) and gastric carcinoma.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Hu H

Authors: Hu H, Li R, Xu R, Zhang S,

Keywords: autoimmune metaplastic atrophic gastritis, incidence, neoplasia, gastric hyperplastic polyps, gastric carcinoma, pepsinogen 1/2 ratio,

#2804 Claudin-18 Is a Sensitive and a Specific Marker for Gastric Neuroendocrine Tumors

Introduction: Antibody-based cancer therapies are emerging as promising therapeutics in oncology, including one in clinical trials that targets claudin-18, a protein expressed in normal gastric epithelium and some gastric adenocarcinoma. We currently have no markers for gastric well-differentiated neuroendocrine tumors (NETs).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Wong M, Huynh C, Kim S, Dhall D, Guindi M,

Keywords: claudin-18, anti-claudin 18, neuroendocrine tumor, neuroendocrine hyperplasia, autoimmune metaplastic atrophic gastritis,